My Neuro Shield delivers precision neurological therapy through breakthrough intranasal atomizer technology — crossing the blood-brain barrier to potentially restore, protect, and optimize brain function.
My Neuro Shield began with something deeply personal. Our founders have watched friends and family members suffer — and in many cases lose their lives — to a wide range of neurological disorders. Those experiences left a lasting mark and a determination to help change the face of neurological diseases for others.
Our founders have more than 50 years of combined experience in the healthcare arena. In the regenerative medicine space, they often met with people and clients facing neurological issues — some at quite serious stages — and felt the frustration of being unable to serve their clients with the resources available to them at the time.
Traditional medicine often touches the surface — tackling the symptoms rather than digging to find the root cause. They refused to believe that was the end of the story. So they searched.
And then, through a fortunate connection, they were introduced to a technology designed to do something remarkable: carry compounds across the blood-brain barrier — the very wall that has kept so many treatments from ever reaching the brain.
That discovery changed everything, because it gave them something to offer people who had been told to lower their expectations. They believe there are alternatives worth exploring for those living with neurological conditions. Every physician takes the Hippocratic Oath — a solemn promise to act in their patients' best interest and, above all, to do no harm — and so does My Neuro Shield. My Neuro Shield was built to answer it differently — to keep searching, to keep reaching for the root cause, and to never stop believing in the people it serves.
Decades of healthcare experience, a shared personal mission, and clinical leadership dedicated to changing the face of neurological disease.
Tara White brings more than 25 years of combined experience across healthcare and regenerative medicine to My Neuro Shield. A graduate of Louisiana Tech University, she co-founded a specialty women's clinic and helped lead medical missions to Guatemala. Her work is also deeply personal: after watching Alzheimer's take several members of her family, she is determined to help change the trajectory of neurological disease — because patients and their families deserve better answers and real alternatives.
Bryan White brings more than 25 years in healthcare and regenerative medicine to My Neuro Shield, with expertise spanning orthopedics, corporate diagnostics, regenerative medicine, and building startups from the ground up. A graduate of Texas A&M University, he has partnered with a range of nationally recognized organizations throughout his career. For Bryan, the mission is personal: having watched too many friends and family affected by neurological disorders, he refuses to accept the current standard of care as the end of the story — and is driven to bring better solutions to the people who need them.
Vincent Jarvis, MD serves as Medical Director of My Neuro Shield. He is board certified in Internal Medicine by the American Board of Internal Medicine (ABIM) and in HIV Medicine by the American Academy of HIV Medicine (AAHIVM). Dr. Jarvis earned his medical degree from the Mount Sinai School of Medicine and a Master of Public Health from Columbia University's Mailman School of Public Health. He specializes in regenerative medicine and stands at the forefront of his field, bringing rigorous clinical judgment and a patient-first philosophy to My Neuro Shield's protocols. His leadership ensures that every therapy the company explores is grounded in medical integrity, scientific evidence, and an unwavering commitment to patient safety.
Cameron Smith serves as a Business Development Manager at My Neuro Shield, where he is passionate about building meaningful relationships and helping people take a proactive approach to their health. He works closely with physicians, healthcare providers, sports teams, and organizations to expand access to innovative regenerative medicine and brain health solutions. A former NCAA Division II collegiate swimmer, swim coach, and personal trainer, Cameron has long been driven by health, performance, and helping others reach their full potential. He earned his Bachelor of Business Administration in Management from the University of Montevallo, building a strong foundation in leadership and relationship building. He believes the strongest partnerships are built on trust, education, and a genuine commitment to helping others.
Jack White serves as a Business Development Manager at My Neuro Shield, where he's on a mission to connect athletes, healthcare professionals, and organizations with proactive brain health solutions. He thrives on building the kind of partnerships that make objective brain health assessment and personalized care far more accessible to the people who need them most. A graduate of Florida State University with a B.B.A. in Sport Management, Jack knows the athletic world from the inside out — the relationships between athletes, coaches, and administrators, and the real decisions that keep teams running. That perspective fuels his passion for athletes, who put their bodies and brains on the line every single day, often without a clear picture of what's happening beneath the surface. Whether he's sitting down with an athletic program, a healthcare provider, or a business leader, Jack's goal stays the same: educate, earn trust, and empower people to take charge of their long-term brain health.
My Neuro Shield's platform is designed to meet the needs of individuals, medical professionals, and sports organizations.
Professional leagues and teams — including the NFL, NHL, NBA, MLB, MLS, UFC, and boxing organizations — as well as NCAA collegiate and high school sports programs and their trainers, seeking evidence-based concussion recovery and cognitive performance protocols for their athletes.
Team Inquiry →
Forward-thinking physicians and clinics integrating My Neuro Shield into their regenerative medicine protocols for neurological patient care and outcome optimization.
Provider Inquiry →
Individuals and families seeking cutting-edge brain health options outside traditional healthcare limitations. My Neuro Shield begins with a pre-consultation to understand your neurological health goals — then pairs you with one of our trusted partner physicians who will oversee your personalized protocol from start to finish.
Schedule Pre-Consult →The following are examples of neurological and central nervous system areas that remain the subject of ongoing scientific research and investigational interest.
Alzheimer's disease is among the most actively researched neurological conditions worldwide and continues to be an area of ongoing scientific study.
Parkinson's disease is a widely studied neurological condition and an area of continued scientific research.
Stroke is one of the most extensively researched areas of neurology and remains a major focus of ongoing scientific study.
Traumatic brain injury and concussion are widely studied areas of neuroscience and remain a continued focus of scientific research and interest.
Chronic traumatic encephalopathy (CTE) is an area of growing scientific research, particularly in the context of repetitive head impacts. As CTE is currently confirmed only post-mortem, related human research is reflected in the TBI/concussion and tau-biomarker studies in our research library.
Post-traumatic stress disorder is a subject of broad and ongoing research across the neuroscience and mental-health communities.
Multiple sclerosis is a well-studied neurological condition that remains an area of ongoing scientific research.
Autism spectrum conditions represent an area of active and evolving scientific inquiry.
PANS and PANDAS are emerging areas of pediatric neuro-immune research that continue to be studied.
My Neuro Shield is powered by the MyndRyte™ Platform, built on Kurve Therapeutics' intranasal delivery technology — a clinically validated drug delivery system engineered to transport compounds directly across the blood-brain barrier with precision and consistency.
The MyndRyte platform leverages targeted olfactory and trigeminal nerve pathways to deliver compounds directly into the CNS — bypassing the blood-brain barrier entirely.
Proprietary vortex atomization generates precisely sized aerosol particles that deposit in the upper nasal cavity, maximizing uptake and minimizing systemic exposure.
Most compounds delivered through traditional IV therapy reach the brain in very small amounts — often less than 1% — because of the blood-brain barrier. The intranasal atomizer takes a different approach. Using controlled particle-dispersion atomization, it is designed to deliver compounds through the upper nasal cavity to access nose-to-brain pathways, with direct CNS absorption of up to approximately 30% reported in intranasal-delivery research. This delivery approach has been studied in more than 20 clinical trials, including studies in Alzheimer's and Parkinson's, as a non-invasive route for delivering compounds to the central nervous system.
Our platform is designed to work with a combination of bioactive compounds that are the focus of ongoing neurological and regenerative-medicine research.
Exosomes are nano-sized extracellular vesicles that cells use to carry signaling molecules. They are an active subject of regenerative-medicine research.
Mesenchymal stem cells are a widely studied cell type of interest in regenerative-medicine and neurological research.
Multilineage-differentiating stress enduring (MUSE) cells are a novel cell type studied within regenerative-medicine research.
Insulin is a well-characterized hormone involved in glucose metabolism that has been studied for its role in the central nervous system.
Immunoglobulin G (IgG) is an antibody studied for its role in immune regulation, including within the central nervous system.
Neuropeptides are signaling molecules studied for their roles in the nervous system across a range of research areas.
We monitor neurological health through a precision set of blood biomarkers — objective, measurable indicators of brain injury, neurodegeneration, and genetic risk. Select a biomarker below to learn more.
Astrocyte Damage Marker
GFAP is a structural protein found exclusively in astrocytes — the support cells of the brain. When brain tissue is injured or undergoing neurodegeneration, astrocytes release GFAP into the bloodstream, making it a highly sensitive blood-based indicator of brain damage.
Axonal Injury & Neurodegeneration Marker
NfL is a structural protein that forms part of the internal scaffolding of neurons (neurofilaments). When axons — the long nerve fibers that transmit signals between neurons — are damaged or destroyed, NfL is released into the cerebrospinal fluid and bloodstream.
Neuronal Injury & Tau Pathology Marker
BD-Tau is a form of the tau protein that originates specifically from neurons in the brain. Unlike total tau measurements that can include tau from peripheral tissues, BD-Tau is brain-specific — providing a cleaner signal of neuronal damage and tau-related pathology.
Genetic Risk & Personalized Medicine Marker
APOE (Apolipoprotein E) is a gene with three variants — ε2, ε3, and ε4 — that plays a critical role in how the brain processes and clears fats, repairs neurons, and manages amyloid beta. Knowing a patient's APOE genotype is one of the most powerful tools in personalized brain health.
Alzheimer's Pathology & Amyloid Cascade Marker
P-Tau 217 is a form of the tau protein that has been abnormally phosphorylated at a specific site — threonine-217 — a modification driven almost exclusively by the accumulation of amyloid beta plaques in the brain. It is one of the most accurate blood-based indicators of Alzheimer's disease pathology currently available.
Both BD-Tau and P-Tau 217 are forms of the tau protein, but they measure fundamentally different biological events and serve distinct clinical purposes.
Brain-Derived Tau
Phosphorylated Tau at Threonine-217
Our integrated system for brain health monitoring and provider-directed protocols.
A guided, provider-directed program — from baseline to results:
Our intranasal atomizer device, designed for provider-directed administration of compounds in clinical or at-home settings.
Comprehensive neurological blood biomarker testing panel to establish your baseline and monitor brain health markers over time.
Our biologics formulary, administered via the MyndRyte intranasal platform under the direction and supervision of a licensed healthcare provider. Our biologics can also be used in other applications via IV and localized injections.
The studies below focus on human clinical trials and studies of intranasal (nose-to-brain) delivery of the compounds used in our platform — insulin, regenerative biologics (stem cells, MUSE cells, and exosomes), and peptides — across neurological and CNS conditions, including TBI and concussion. Several were conducted using the Kurve ViaNase device. Click any study to open it.
Studies sourced from peer-reviewed literature (PubMed / PMC), ClinicalTrials.gov, and kurveresearch.com. Listings focus on human clinical trials and studies; some are investigational or ongoing. Results are not a guarantee of outcomes. Consult a licensed physician before beginning any protocol.
Education, research, and perspectives on proactive brain health, regenerative medicine, and the science behind My Neuro Shield.
Whether you're a patient, provider, or sports organization — My Neuro Shield has a program designed for you. Start with a consultation today.
Interested in exploring regenerative therapies? Complete our confidential online prescreen questionnaire. A licensed provider will review your responses to help determine whether you may be a candidate.
Start the Prescreen Questionnaire →Confidential — for clinical screening use only. Completing this form does not guarantee eligibility or treatment.
Have questions about our technology, products, or partnership opportunities? We'd love to connect.